Departments and Services | For Patients | Research & Trials | Education | Find a Doctor


Search:
Division of Infectious Disease
 
    
Division of Infections Disease
 
Home
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Penn CFAR
Botswana-UPenn Partnership
Seminars
Faculty
Adjunct Faculty
Administrative Contacts
Outpatient Clinics
News

Faculty

faculty photo

Karam C. Mounzer, MD

Clinical Associate Professor of Medicine
Attending Physician, Penn Presbyterian Medical Center
Department: Medicine

Contact information
1233 Locust Street
Philadelphia, PA 19107
Office: 215-790-1788
Fax: 215-732-5490
Education:
Bachelor (Experimental Sciences and French Literature)
Notre Dame Jamhour- Jesuite School 1982-1985, 1985.
MD
Saint Joseph University (Pre-Med & Med combined) Faculty of Medicine, Lebanon 1985-1992, 1992.
Post-Graduate Training
Internal Medicine, Cooper Health System - University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Camden , 1992-1993.
Residency, Cooper Health System - University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Camden , 1993-1995.
Infectious Diseases Fellowship, Cooper Health System - University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Camden , 1995-1997.
Certifications
Diplomate, American Board of Internal Medicine , 1995.
Diplomate, American Board of Infectious Diseases , 1997.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical Development of new antiretroviral agents

Description of Clinical Expertise

Treatment of Multi drug Resistant HIV virus, HIV-HCV co-infection

Description of Other Expertise

Suboxone Clinic for HIV infected opioid-addicted patients

Selected Publications

Sulkowski MS, Naggie S, Lalezari J, Fessel WJ, Mounzer K, Shuhart M, Luetkemeyer AF, Asmuth D, Gaggar A, Ni L, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Rodriguez-Torres M, Dieterich D; PHOTON-1 Investigators.: Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection. JAMA 4, July 2014.

Baligh R Yehia, Leslie Stewart, Florence Momplaisir, Aaloke Moody, Carol Holtzman, Lisa Jacobs, Janet Hines, Karam Mounzer, Karen Glanz, Joshua P Metlay and Judy A Shea : Mapping Barriers to Retention in HIV Care and ART Adherence to Andersen’s Behavioral Model 9th International Conference on HIV Treatment and Prevention Adherence, June 2014.

Sarah Smith, Karam Mounzer: Isolated Hepatitis B surface antigenemia in a HIV-1 positive infected individual Article type: Correspondence AIDS 2014.

Antonella Castagna, Franco Maggiolo, Giovanni Penco, David Wright, Anthony Mills, Robert Grossberg, Jean-Michel Molina, Julie Chas, Jacques Durant, Santiago Moreno, Manuela Doroana, Mounir Ait-Khaled, Jenny Huang, Sherene Min, Ivy Song, Cindy Vavro, Garrett Nichols, Jane M. Yeo, for the VIKING-3 Study Group : Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir- Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study J Infect Dis 2014.

Maribel Rodriguez-Torres1,Susanna Naggie2, Mark Sulkowski3, Jacob Lalezari4, W. Jeffrey Fessel5, Karam Mounzer6, Margaret Shuhart7, Annie Luetkemeyer8, David Asmuth9, Anuj Gaggar10, Liyun Ni10, Evguenia Svarovskaia10, William Symonds10, John McHutchison10, Douglas Dieterich11 : Sofosbuvir Plus Ribavirin For HCV Genotype 1-3 Infection in HIV Co-infected Patients (PHOTON-1) HIV Drug Therapy in the Americas Conference 2014.

Vincent Lo Re III, Kenneth Lynn, Emily Stumm, Jin Long, Melissa S. Nezamzadeh, Joshua F. Baker, Angela Kapalko2, Karam Mounzer, Pablo Tebas, Jay R. Kostman, Mary B. Leonard: Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women ID Week 2014.

Tomescu C1, Liu Q2, Ross BN1, Yin X2, Lynn K3, Mounzer KC4, Kostman JR3, Montaner LJ1.: A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers. PLoS One 2014.

Momplaisir F, Mounzer K, Long JA.: Preventive cancer screening practices in HIV-positive patients. AIDS Care 2014.

K Mounzer1, B Rashbaum2, C Lucasti3, K Melbourne4, P Kwon4, T Nguyen4: “Simplification to elvitegravir/cobicistat/emtricitabine/tenofovir DF from ritonavir-boosted protease inhibitor plus emtricitabine/tenofovir DF maintains HIV suppression and improves fasting triglycerides at week 48” the International Workshop on Co-morbidities and Adverse Drug Reactions in HIV 2014.

Sean Patro, Sharmistha Pal, Yingtao Bi, Kenneth Lynn, Karam Mounzer, Jay Kostman, Ramana Davuluri, and Luis Montaner.: "Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-related ISG/Bcl2-family Gene Expression in Chronic HIV-1 Infected Subjects" Journal of Virology 2014.

back to top
Last updated: 11/20/2014
The Trustees of the University of Pennsylvania